Skip to main content
SpringerLink
Log in

The “depressive” face of osteoporosis and the “osteoporotic” face of depression

  • Review
  • Published:
Hormones Aims and scope Submit manuscript

Abstract

Osteoporosis and depression are two chronic diseases that affect large population groups with great impact on morbidity, mortality and quality of life. An association between osteoporosis and depression has been described in the literature. Definitely, limited data suggest that osteoporosis may enhance depressive symptoms, while far more studies have shown that depression adversely affects bone density and increases fracture risk. However, neither causation nor a firm pathophysiological connection has been established. Thus the correlation of these diseases is still under research. This review comments on a plausible causative relationship and underlying mechanisms that might elucidate the link between two very common diseases. We describe the possible impact of osteoporosis on moods and the (better established) effect of depression on bone health. We also describe the effect of medication and review hormonal and cellular signals that may explain this effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rachner TD, Khosla S, Hofbauer LC, 2011 Osteoporosis: now and the future. Lancet 377: 1276–1287.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Cummings SR, Melton LJ, 2002 Osteoporosis I: epidemiology and outcomes of osteoporotic fractures. Lancet 359: 1761–1767.

    Article  PubMed  Google Scholar 

  3. Johnell O, Kanis J, 2005 Epidemiology of osteoporotic fractures. Osteoporos Int 16: Suppl 2: 3–7.

    Article  Google Scholar 

  4. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA, 1999 Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353: 878–882.

    Article  PubMed  CAS  Google Scholar 

  5. Sambrook P, Cooper C, 2006 Osteoporosis. Lancet 367: 2010–2018.

    Article  PubMed  CAS  Google Scholar 

  6. Browner WS, Pressman AR, Nevitt MC, Cummings SR, 1996 Mortality following fractures in older women. The study of osteoporotic fractures. Arch Intern Med 156: 1521–1525.

    Article  PubMed  CAS  Google Scholar 

  7. Papaioannou A, Kennedy CC, Ioannidis G, et al, 2009 The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study. Osteoporos Int 20: 703–714.

    Article  PubMed  CAS  Google Scholar 

  8. Salaffi F, Cimmrno MA, Malavolta N et al, 2007 The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study. J Rheumatol 34: 1551–1560.

    PubMed  Google Scholar 

  9. Nevitt M, Ettinger B, Black D, et al, 1998 The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 128: 793–800.

    Article  PubMed  CAS  Google Scholar 

  10. Cooper C, Jacob F, Chinn C, et al, 2008 Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of severe Osteoporosis (OSSO). Osteoporosis Int 19: 493–501.

    Article  CAS  Google Scholar 

  11. Gold DT, Shipp KM, Lyles KW, 1998 Managing patients with complications of osteoporosis. Endocrinol Metab Clin North Am 27: 485–496.

    Article  PubMed  CAS  Google Scholar 

  12. Becker DJ, Kilgore ML, Morrisey MA, 2010 The societal burden of osteoporosis. Curr Rheumatol Rep 12: 186–191.

    Article  PubMed  Google Scholar 

  13. Dempster DW, 2011 Osteoporosis and the burden of osteoporosis-related fractures. Am J Manag Care 17: Suppl 6: 164–169.

    Google Scholar 

  14. Kanis JA, Johnell O, 2005 Requirements for DXA for the management of osteoporosis in Europe. Osteoporos Int 16: 229–238.

    Article  PubMed  CAS  Google Scholar 

  15. Pratt LA, Brody DJ, 2008 Depression in the United States household population, 2005–2006. NCHS Data Brief 7: 1–8.

    Google Scholar 

  16. https://doi.org/www.merckmanuals.com/professional/psychiat-ric_disorders/mood_disorders/depressive_disorders.html. Last full review/revision December 2009 by William Coryell, MD. Content last modified December 2009.

  17. Whooley MA, Simon GE, 2000 Primary care: Managing depression in medical outpatients. N Engl J Med 343: 1942–1950.

    Article  PubMed  CAS  Google Scholar 

  18. Ramasubbu R, Taylor VH, Samaan Z, et al, 2012 The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and select comorbid medical conditions. Ann Clin Psychiatry 24: 91–109.

    PubMed  Google Scholar 

  19. Mussolino M, 2005 Depression and Hip Fracture Risk: The NHANES I Epidemiologic Follow-Up Study. Public Health Reports 120: 71–75.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Michelson D, Stratakis C, Hill L et al, 1996 Bone mineral density in women with depression. N Engl J Med 335: 1176–1181.

    Article  PubMed  CAS  Google Scholar 

  21. Gold DT, Solimeo S. 2006 Osteoporosis and Depression: a historical perspective. Curr Osteoporos Rep 4: 134–139.

    Article  PubMed  Google Scholar 

  22. Erez HB, Weller A, Vaisman N, Kreitler S, 2012 The relationship of depression, anxiety and stress with low bone mineral density in post-menopausal women. Arch Osteoporos 7: 247–255.

    Article  PubMed  Google Scholar 

  23. Cizza G, Primma S, Coyle M, Gourgiotis L, Csako G, 2010 Depression and osteoporosis: a research synthesis with meta-analysis. Horm Metab Res 42: 467–482.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Reid KJ, Harker J, Bala MM et al, 2011 Epidemiology of chronic non-cancer pain in Europe: narrative review of prevalence, pain treatments and pain impact. Curr Med Res Opin 27: 449–462.

    Article  PubMed  Google Scholar 

  25. Uebelhart B, Rizzoli R, 2005 Osteoporosis and pain or is osteoporosis painful? Rev Med Suisse 1: 1662–1165.

    PubMed  CAS  Google Scholar 

  26. Salaffi F, Cimmino MA, Malavolta N, et al, 2007 The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study. J. Rheumatol 34: 1551–1560.

    PubMed  Google Scholar 

  27. Adami S, Maugeri D, Toscano V, et al, 2011 Baseline characteristics of the population enrolled in the Italian Observational Study on Severe Osteoporosis (ISSO). Clin Exp Rheumatol 29: 477–484.

    PubMed  CAS  Google Scholar 

  28. Coelho R, Silva C, Maia A, et al, 1999 Bone mineral density and depression: a community study in women. J Psychosom Res 46: 29–35.

    Article  PubMed  CAS  Google Scholar 

  29. Silverman SL, Shen W, Minshall ME, Xie S, Moses KH, 2007 Prevalence of depressive symptoms in postmenopausal women with low bone mineral density and/ or prevalent vertebral fracture: results from the Multiple Outcomes of Raloxifene Evaluation (MORE) study. J Rheumatol 34: 140–144.

    PubMed  Google Scholar 

  30. Kamholz B, Unützer J, 2007 Depression after hip fracture. J Am Genatr Soc 55: 126–127.

    Article  Google Scholar 

  31. The EuroQol Group, 1990 EuroQol a new facility for the measurement of health-related quality of life. Health Policy 16: 199–208.

    Article  Google Scholar 

  32. Aloumanis K, Karras D, Drossinos V, Korelis E, Polydorakis A, 2011 Fracture incidence, quality of life, and back pain during 18-months treatment with teriparatide in greek postmenopausal women with osteoporosis: results from the european forsteo observational study. J Osteoporos 2011: 2011: 510398.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Jacka F, Pasco J, Henry M, et al, 2005 Depression and bone mineral density in a community sample of perimenopausal women: Geelong osteoporosis Study. Menopause 12: 88–91.

    Article  PubMed  Google Scholar 

  34. Eskandari F, Martinez P, Torvik S, et al, 2007 Low Bone Mass in Premenopausal Women With Depression. Arch Intern Med 167: 2329–2336.

    Article  PubMed  Google Scholar 

  35. Wu Q, Magnus JH, Liu J, Bencaz AF, Hentz JG, 2009 Depression and low bone mineral density: a meta-analysis of epidemiologic studies. Osteoporos Int 20: 1309–1320.

    Article  PubMed  CAS  Google Scholar 

  36. Weller EB, Weller RA, Kloos AL, Hitchcock S, Kim WJ, Zemel B, 2007 Impact of depression and its treatment on the bones of growing children. Curr Psychiatry Rep 9: 94–98.

    Article  PubMed  Google Scholar 

  37. Cizza G, Ravn P, Chrousos GP, Gold PW, 2001 Depression: a major, unrecognized risk factor for osteoporosis? Trends Endocrinol Metab 12: 198–203.

    Article  PubMed  CAS  Google Scholar 

  38. Robbins J, Hirsch C, Whitmer R, Cauley J, Harris T, 2001 The association of bone mineral density and depression in an older population. J Am Geriatr Soc 49: 732–736.

    Article  PubMed  CAS  Google Scholar 

  39. Schweiger U, Deuschle M, Korner A, et al, 1994 Low lumbar bone mineral density in patients with major depression. Am J Psychiatry 151: 1691–1693.

    Article  PubMed  CAS  Google Scholar 

  40. Halbreich U, Rojansky N, Palter S, et al, 1995 Decreased bone mineral density in medicated psychiatric patients. Psychosom Med 57: 485–491.

    Article  PubMed  CAS  Google Scholar 

  41. Dorn LD, Susman EJ, Pabst S, Huang B, Kalkwarf H, Grimes S, 2008 Association of depressive symptoms and anxiety with bone mass and density in ever-smoking and never-smoking adolescent girls. Arch Pediatr Adolesc Med 162: 1181–1188.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Atteritano M, Lasco A, Mazzaferro S, et al, 2011 Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression. Intern Emerg Med: 2011 May 17. [Epub ahead of print]

  43. Erez HB, Weller A, Vaisman N, Kreitler S, 2012 The relationship of depression, anxiety and stress with low bone mineral density in post-menopausal women. Arch osteoporos 7: 247–55.

    Article  PubMed  Google Scholar 

  44. Fazeli PK, Mendes N, Russell M, Herzog DB, Klibanski A, Misra M, 2013 Bone density characteristics and major depressive disorder in adolescents. Psychosom Med 75: 117–123.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  45. Dorn LD, Beal SJ, Kalkwarf HJ, Pabst S, Noll JG, Susman EJ, 2013 Longitudinal impact of substance use and depressive symptoms on bone accrual among girls aged 11–19 years. J Adolesc Health 52: 393–399.

    Article  PubMed  Google Scholar 

  46. Yazici KM, Akinci A, Sutcu A, Ozcakar L, 2003 Bone mineral density in premenopausal women with major depressive disorder. Psychiatry Res 117: 271–275.

    Article  PubMed  Google Scholar 

  47. Yirmiya R, Bab I, 2009 Major depression is a risk factor for low bone mineral density: a meta-analysis. Biol Psychiatry 66: 423–432.

    Article  PubMed  Google Scholar 

  48. Amsterdam JD, Hooper MB, 1998 Bone density measurement in major depression. Prog Neuro-Psychopharmacol Biol Psychiatry 22: 267–277.

    Article  CAS  Google Scholar 

  49. Malik P, Gasser RW, Moncayo R, et al, 2013 Bone mineral density and bone metabolism in patients with major depressive disorder without somatic comorbidities. Prog Neuropsychopharmacol Biol Psychiatry 44: 58–63.

    Article  PubMed  CAS  Google Scholar 

  50. Lapi F, Simonetti M, Michieli R, et al, 2012 Assessing 5-year incidence rates and determinants of osteoporotic fractures in primary care. Bone 50: 85–90.

    Article  PubMed  CAS  Google Scholar 

  51. Haney EM, Warden SJ, 2008 Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: Evidence from clinical studies. J Musculoskelet Neuronal interact 8: 133–145.

    PubMed  CAS  Google Scholar 

  52. Herrán A, Amado JA, Garcia-Unzueta MT, et al, 2000 Increased bone remodeling in first-episode major depressive disorder. Psychosom Med 62: 779–782.

    Article  PubMed  Google Scholar 

  53. Aydin H, Mutlu N, Akbas NB, 2011 Treatment of a major depression episode suppresses markers of bone turnover in premenopausal women. J Psychiatr Res 45: 1316–1320.

    Article  PubMed  Google Scholar 

  54. Morley JE, 2007 Falls-where do we stand? Mo Med 104: 63–67.

    PubMed  Google Scholar 

  55. Byers AL, Sheeran T, Mlodzianowski AE, Meyers BS, Nassisi P, Bruce ML, 2008 Depression and risk for adverse falls in older home health care patients. Res Gerontol Nurs 1: 245–251.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Eggermont LH, Penninx BW, Jones RN, Leveille SG, 2012 Depressive symptoms, chronic pain, and falls in older community-dwelling adults: the MoBILIZE Boston Study. J Am Geriatr Soc 60: 230–237.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Darowski A, Chambers SA, Chambers DJ, 2009 Antidepressants and falls in the elderly. Drugs Aging 26: 381–394.

    Article  PubMed  CAS  Google Scholar 

  58. Van den Berg M, Verdijk NA, Leusink GL, et al, 2011 Depression after low-energy fracture in older women predicts future falls: a prospective observational study. BMC Geriatr 7;11:73.

    Article  Google Scholar 

  59. Iaboni A, Flint AJ, 2013 The Complex interplay of Depression and Falls in older Adults: A Clinical Review. Am J geriatr Psychiatry 21: 484–492.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Whitson HE, Sanders L, Pieper CF, et al, 2008 Depressive symptomatology and fracture risk in community-dwelling older men and women. Aging Clin Exp Res 20: 585–592.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Whooley MA, Kip KE, Cauley JA, Ensrud KE, Nevitt MC, Browner WS, 1999 Depression, falls, and risk of fracture in older women. Study of Osteoporotic Fractures Research Group. Arch Intern Med 159: 484–490.

    Article  PubMed  CAS  Google Scholar 

  62. Søgaard AJ, Joakimsen RM, Tverdal A, Fønnebø V, Magnus JH, Berntsen GK, 2005 Long-term mental distress, bone mineral density and non-vertebral fractures. The Tromso Study. Osteoporos Int. 16:887–897.

    Article  PubMed  Google Scholar 

  63. Forsén L, Meyer HE, Søgaard AJ, Naess S, Schei B, Edna TH, 1999 Mental distress and risk of hip fracture. Do broken hearts lead to broken bones? J Epidemiol Community Health 53: 343–347.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Piscitelli P, Metozzi A, Benvenuti E, et al, 2012 Connections between the outcomes of osteoporotic hip fractures and depression, delirium or dementia in elderly patients: rationale and preliminary data from the CODE study. Clin Cases Miner Bone Metab 9: 40–44.

    PubMed  PubMed Central  Google Scholar 

  65. Diem SJ, Blackwell TL, Stone KL, et al, 2007 Study of Osteoporotic Fractures. Depressive symptoms and rates of bone loss at the hip in older women. J Am Geriatr Soc 55: 824–831.

    Article  PubMed  Google Scholar 

  66. Diem SJ, Blackwell TL, Stone KL, et al, 2007 Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med 167: 1240–1245.

    Article  PubMed  Google Scholar 

  67. Herbert C, McKean M, Dantz B, 2010 Osteoporosis in depression: Which patients are at risk? Chronic pain perspectives. 9(4) 9–12, 25.

    Google Scholar 

  68. Rizzoli R, Cooper C, Reginster JY, et al, 2012 Antidepressant medications and osteoporosis. Bone 51: 606–613.

    Article  PubMed  CAS  Google Scholar 

  69. Wu Q, Bencaz AF, Hentz JG, Crowell MD, 2012 Selective serotonin reuptake inhibitor treatment and risk of fractures: ameta-analysis of cohort and case-control studies Osteoporos Int 23: 365–375.

    Article  PubMed  CAS  Google Scholar 

  70. Bab I, Yirmiya R, 2010 Depression, Selective Serotonin Reuptake Inhibitors, and Osteoporosis. Curr Osteoporos Rep 8: 185–191.

    Article  PubMed  Google Scholar 

  71. Warden SJ, Hassett SM, Bond JL, et al, 2010 Psychotropic drugs have contrasting skeletal effects that are independent of their effects on physical activity levels. Bone 46: 985–992.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  72. Ilias I, Alesci S, Gold P, Chrousos G, 2006 Depression and osteoporosis in men: association or casual link? Hormones (Athens) 5: 9–16.

    Article  Google Scholar 

  73. Whooley MA, Cauley JA, Zmuda JM, Haney EM, Glynn NW, 2004 Depressive symptoms and bone mineral density in older men. J Geriatr Psychiatry Neurol 17: 88–92.

    Article  PubMed  Google Scholar 

  74. Mussolino ME, Jonas BS, Looker AC, 2004 Depression and bone mineral density in young adults: results from NHANES III. Psychosom Med 66: 533–537.

    Article  PubMed  Google Scholar 

  75. Oh SM, Kim HC, Ahn SV, Rhee Y, Suh I, 2012 Association between depression and bone mineral density in community-dwelling older men and women in Korea. Maturitas 71: 142–146.

    Article  PubMed  Google Scholar 

  76. Laudisio A, Marzetti E, Cocchi A, Bernabei R, Zuccalà G, 2008 Association of depressive symptoms with bone mineral density in older men: a population-based study. Int J Geriatr Psychiatry 23: 1119–1126.

    Article  PubMed  Google Scholar 

  77. Kotsalou I, Valsamaki P, Chatzipetrou A, Fountos G, Adraktas A, Gerali S, 2011 Is major depression in middle-aged men correlated with bone density decrease? A study on Greek population. Hell J Nucl Med 14: 331–336.

    PubMed  Google Scholar 

  78. Hidaka BH. 2012 Depression as a disease of modernity: explanations for increasing prevalence. J Affect Disord 140: 205–214.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Mamplekou E, Bountziouka V, Psaltopoulou T, et al, 2010 Urban environment, physical inactivity and unhealthy dietary habits correlate to depression among elderly living in eastern Mediterranean islands: the MEDIS (MEDiterranean ISlands Elderly) study. J Nutr Health Aging 14: 449–455.

    Article  PubMed  CAS  Google Scholar 

  80. Ischaki E, Gratziou C, 2009 Smoking and depression: Is smoking cessation effective? Ther Adv Respir Dis 3: 31–38.

    Article  PubMed  Google Scholar 

  81. Palfai TP, Cheng DM, Samet JH, Kraemer KL, Roberts MS, Saitz R, 2007 Depressive symptoms and subsequent alcohol use and problems: a prospective study of medical inpatients with unhealthy alcohol use. J Stud Alcohol Drugs 68: 673–680.

    Article  PubMed  Google Scholar 

  82. Uguz F, Sahingoz M, Gezginc K, Ayhan MG, 2011 Quality of life in postmenopausal women: the impact of depressive and anxiety disorders. Int J Psychiatry Med 41: 281–292.

    Article  PubMed  Google Scholar 

  83. Koster JB, Kühbauch BA, 2011 Vitamin D deficiency and psychiatric patients. Tijdschr Psychiatr 53: 561–565.

    PubMed  CAS  Google Scholar 

  84. Takeda S, 2009 Osteoporosis: a neuroskeletal disease? Int J Biochem Cell Biol 41: 455–459.

    Article  PubMed  CAS  Google Scholar 

  85. Mezuk B, Eaton WW, Golden SH, 2008 Depression and osteoporosis: epidemiology and potential mediating pathways. Osteoporos Int 19:1–12.

    Article  PubMed  CAS  Google Scholar 

  86. Licinio J, Wong ML, 1999 The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol Psychiatry 4: 317–327.

    Article  PubMed  CAS  Google Scholar 

  87. Rush AJ, Schlesser MA, Orsulak PJ, et al, 1997 Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression. Biol Psychiatry 41: 915–928.

    Article  PubMed  CAS  Google Scholar 

  88. Rush AJ, Giles DE, Schlesser MA et al, 1996 The dexamethasone suppression test in patients with mood disorders. J Clin Psychiatry 57: 470–484.

    Article  PubMed  CAS  Google Scholar 

  89. Cizza G, Ronsaville DS, Kleitz H, et al, 2012 Clinical subtypes of depression are associated with specific metabolic parameters and circadian endocrine profiles in women: the power study. PLoS One, 7:e28912.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  90. Warden SJ, Robling AG, Haney EM, Turner CH, Bliziotes MM, 2010 The emerging role of serotonin (5-hy-droxytryptamine) in the skeleton and its mediation of the skeletal effects of low-density lipoprotein receptor-related protein 5 (LRP5). Bone 46: 4–12.

    Article  PubMed  CAS  Google Scholar 

  91. Bliziotes M, 2010 Update in Serotonin and Bone. J Clin Endocrinol Metab 95: 4124–4132.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  92. Karsenty G, Ferron M, 2012 The contribution of bone to whole-organism physiology. Nature 18: 481: 314–320.

    Article  CAS  Google Scholar 

  93. Yirmiya R, Goshen I, Bajayo A, et al, 2006 Depression induces bone loss through stimulation of the sympathetic nervous system. PNAS 103: 16876–16881.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  94. Ducy P, Karsenty G, 2010 The two faces of serotonin in bone biology. J Cell Biol 191(1):7–13.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  95. Baron R, Hesse E, 2012 Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives. J Clin Endocrinol Metab 97: 311–325.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  96. Krishnan V, Bryant HU, Macdougald OA, 2006 Regulation of bone mass by Wnt signaling. J Clin invest 116: 1202–1209.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  97. van Dijk SC, de Herder WW, Kwekkeboom DJ, et al, 2012 5-HIAA excretion is not associated with bone metabolism in carcinoid syndrome patients. Bone 50: 1260–1265.

    Article  PubMed  CAS  Google Scholar 

  98. Yadav V, Oury F, Suda N, et al, 2009 Leptin regulation of bone mass, appetite and energy expenditure relies on its ability to inhibit serotonin synthesis in the brainstem. Cell. 138: 976–989.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  99. Gimble JM, 2011 Leptin’s Balancing Act Between Bone and Fat. JBMR 26: 1694–1697.

    Article  CAS  Google Scholar 

  100. Cizza G, Nguyen VT, Eskandari F, et al, 2010 Low 24-hour adiponectin and high nocturnal leptin concentrations in a case-control study of community-dwelling premenopausal women with major depressive disorder: the Premenopausal, Osteopenia/Osteoporosis, Women, Alendronate, Depression (POWER) study. J Clin Psychiatry 71: 1079–1087.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  101. Kahl KG, Greggersen W, Rudolf S, et al, 2006 Bone mineral density, bone turnover, and osteoprotegerin in depressed women with and without borderline personality disorder. Psychosom Med 68: 669–674.

    Article  PubMed  Google Scholar 

  102. Pérez-López FR, 2007 Vitamin D and its implications for musculoskeletal health in women: an update. Maturitas 58: 117–137.

    Article  PubMed  CAS  Google Scholar 

  103. Lee DM, Tajar A, O’Neill TW, et al, 2011 Lower vitamin D levels are associated with depression among community-dwelling European men. J Psychopharmacol 25: 1320–1328.

    Article  PubMed  CAS  Google Scholar 

  104. Jorde R, Sneve M, Figenschau Y, Svartberg J, Waterloo K, 2008 Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J intern Med 264: 599–609.

    Article  PubMed  CAS  Google Scholar 

  105. Zhao G, Ford ES, Li C, Balluz LS, 2010 No associations between serum concentrations of 25-hydroxyvitamin D and parathyroid hormone and depression among US adults. Br J Nutr 104: 1696–1702

    Article  PubMed  CAS  Google Scholar 

  106. Walker MD, Rubin M, Silverberg SJ. 2013 Nontraditional manifestations of primary hyperparathyroidism J Clin Densitom 16: 40–47.

    Article  PubMed  PubMed Central  Google Scholar 

  107. Dobolyi A, Dimitrov E, Palkovits M, Usdin TB, 2012 The neuroendocrine functions of the parathyroid hormone 2 receptor. Front Endocrinol (Lausanne). 2012;3:121.

    Article  CAS  Google Scholar 

  108. Herrán A, Amado JA, García-Unzueta MT, Vázquez-Barquero JL, Perera L, González-Macías J, 2000 Increased bone remodeling in first-episode major depressive disorder. Psychosom Med 62: 779–782.

    Article  PubMed  Google Scholar 

  109. Haney EM, Warden SJ, Bliziotes MM, 2010 Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management? Bone 46: 13–17.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Private Medical Office, “Asklepieion” Athens General Hospital, Athens, Greece

    Kyriakos Aloumanis & Kostantinos Mavroudis (Former Director)

  2. Endocrinology Department, “Asklepieion” Athens General Hospital, Athens, Greece

    Kostantinos Mavroudis (Former Director)

Authors
  1. Kyriakos Aloumanis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kostantinos Mavroudis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kyriakos Aloumanis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aloumanis, K., Mavroudis, K. The “depressive” face of osteoporosis and the “osteoporotic” face of depression. Hormones 12, 350–362 (2013). https://doi.org/10.1007/BF03401301

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03401301

Key words

Search

Navigation